A conformation hypothesis for the suppressor and promoter functions of p53 in cell growth control and in cancer
- PMID: 1682937
- DOI: 10.1098/rspb.1991.0100
A conformation hypothesis for the suppressor and promoter functions of p53 in cell growth control and in cancer
Abstract
Cancer is a genetic disease caused by defective control of cell proliferation. As cancer cells divide, the genetic defect is inherited by each daughter cell, leading to tumour development with possible progression to malignancy. The identification of those genes linked with cancer is essential for our understanding of the regulation of cell proliferation and for the therapeutic management of cancer cell growth. Recent studies have revealed that p53 is the most commonly affected gene in human cancer. It is a single copy gene and functions in the regulation of cell proliferation. Mutation of p53 is linked with tumour development, and this may involve abnormal functioning of mutant p53 protein. A mutant allele of p53 is functionally temperature-sensitive and can promote or suppress cell proliferation. The tertiary structure of the mutant protein is also sensitive to temperature and adopts promoter and suppressor forms of p53. A conformation model for the functioning of p53 proposes that wild-type p53 is induced to change from suppressor to promoter form during the cell growth response. This model predicts that any mutation that deregulates the normal control of p53 conformation may lead to cancer.
Similar articles
-
The role of p53 in the normal control of cell proliferation.Curr Opin Cell Biol. 1991 Apr;3(2):282-6. doi: 10.1016/0955-0674(91)90153-p. Curr Opin Cell Biol. 1991. PMID: 1953903 Review.
-
Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation.Cell. 1991 May 31;65(5):765-74. doi: 10.1016/0092-8674(91)90384-b. Cell. 1991. PMID: 2040013
-
Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.Oncogene. 2001 Jun 7;20(26):3409-19. doi: 10.1038/sj.onc.1204457. Oncogene. 2001. PMID: 11423991
-
Forms and functions of p53.Semin Cancer Biol. 1994 Jun;5(3):211-9. Semin Cancer Biol. 1994. PMID: 7948949 Review.
-
p53 mutation heterogeneity in cancer.Biochem Biophys Res Commun. 2005 Jun 10;331(3):834-42. doi: 10.1016/j.bbrc.2005.03.190. Biochem Biophys Res Commun. 2005. PMID: 15865939 Review.
Cited by
-
Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells.J Virol. 1998 Aug;72(8):6348-55. doi: 10.1128/JVI.72.8.6348-6355.1998. J Virol. 1998. PMID: 9658074 Free PMC article.
-
TP53: an oncogene in disguise.Cell Death Differ. 2015 Aug;22(8):1239-49. doi: 10.1038/cdd.2015.53. Epub 2015 May 29. Cell Death Differ. 2015. PMID: 26024390 Free PMC article. Review.
-
Modification of p53 protein profile by gamma irradiation followed by methyl donor starvation.Mol Cell Biochem. 2006 Dec;293(1-2):15-21. doi: 10.1007/s11010-006-1170-8. Epub 2006 Jun 9. Mol Cell Biochem. 2006. PMID: 16767497
-
Wild-type p53 adopts a 'mutant'-like conformation when bound to DNA.EMBO J. 1993 Mar;12(3):1021-8. doi: 10.1002/j.1460-2075.1993.tb05743.x. EMBO J. 1993. PMID: 8458320 Free PMC article.
-
The p53-mediated G1 checkpoint is retained in tumorigenic rat embryo fibroblast clones transformed by the human papillomavirus type 16 E7 gene and EJ-ras.Mol Cell Biol. 1995 Mar;15(3):1446-54. doi: 10.1128/MCB.15.3.1446. Mol Cell Biol. 1995. PMID: 7862138 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous